Prevention and treatment of respiratory consequences induced by sulfur mustard in Iranian casualties

International Journal of Preventive Medicine

Volumn 4, Issue 4, 2013, Pages 383-389

  Razavi, Seyed M ^a   Salamati, Payman ^a   Harandi, Ali Amini ^b   Ghanei, Mostafa ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chemical warfare; Lung injury; Mustard gas

Indexed keywords

ACETYLCYSTEINE; ANTIBIOTIC AGENT; ANTIOXIDANT; AZITHROMYCIN; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLARITHROMYCIN; CORTICOSTEROID; GAMMA1B INTERFERON; HERBACEOUS AGENT; IPRATROPIUM BROMIDE; LONG ACTING DRUG; MAGNESIUM; METHYLPREDNISOLONE ACETATE; MORPHINE; MUCOLYTIC AGENT; MUSTARD GAS; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN; PLANT EXTRACT; PREDNISOLONE; PREDNISONE; SALBUTAMOL; SILDENAFIL; THYME EXTRACT; UNCLASSIFIED DRUG;

ACCIDENT; AIR; ARTICLE; BRONCHIOLITIS; BRONCHIOLITIS OBLITERANS; BRONCHITIS; BRONCHOSCOPY; CHEMICAL INJURY; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EXAMINATION; DISEASE EXACERBATION; DRUG MECHANISM; ENDOSCOPIC THERAPY; ETHNIC GROUP; HUMAN; INFLAMMATION; IRANIAN; LARYNX SPASM; LOW LEVEL LASER THERAPY; LUNG INJURY; LUNG TRANSPLANTATION; MOISTURE; NEODYMIUM YAG LASER; PALLIATIVE THERAPY; PATIENT MONITORING; PHYSIOTHERAPY; PULMONARY HYPERTENSION; PULMONARY REHABILITATION; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INJURY; STENT; SYMPTOM; SYSTEMATIC REVIEW; THYME; TRACHEOSTOMY;

EID: 84877759199     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Rowell M, Kehe K, Balszuweit F, Thiermann H. The chronic effects of sulfur mustard exposure. Toxicology 2009;263:9-11.
2. Khateri SH, Ghanei M, Keshavarz S, Soroush M, Haines D. Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 2003;45:1136-43.
3. Kehe K, Balszuweit F, Emmler J, Krepple H, Jochum M, Thiermann H. Sulfure mustard research: Strategies for the development of improved medical therapy. Eplasty 2008;8:312-32.
4. Foroutan A. Medical notes on the chemical warfare. Kowsar Med J 1997;2:159-77.
5. Graham JS, Chilcott RP, Rice P, Milner SM, Hurst CG, Maliner BI. Wound healing of cutaneous sulfure mustard injuries: Strategies for the development of improved therapies. J Burns Wounds 2005;4:e1.
6. Koch WD. Direkte Kriegserkrankung durch einwirkung chemischer mittel. In: Aschoff L, editor. Pathologische anatomie. Leipzig, Germany: JA Barth; 1921. p. 526-36.
7. Ghasemi Broumand M, Karamy GH, Pourfarzam SH, Emadi SN, Ghasemi H. Late concurrent ophthalmic, respiratory, coetaneous and psychiatric complications of chemical weapons exposure in 479 war patients. Daneshvar Med 2007;70:81-92.
8. Collumbine H. Medical aspects of mustard gas poisoning. Nature 1947;4031:151-3.
9. Balali M, Hefazi M. The pharmacology, toxicology, and medical treatment of sulfur mustard poisoning. Fundam Clin Pharmacol 2005;10:297-315.
10. Safarinejad M, Moosavi SA, Montazeri B. Ocular injuries caused by mustard gas: Diagnosis, treatment and medical defense. Mil Med 2001;166:67-70.
11. Borak J, Sidell FR. Agents of chemical warfare: Sulfur mustard. Ann Emerg Med 1992;21:303-8.
12. Wattana M, Bey T. Mustard gas or sulfur mustard: An old chemical agent as a new terrorist treat. Prehosp Disaster Med 2009;24:19-29.
13. Kehe K, Szinicz L. Medical aspects of sulfur mustard poisoning. Toxicology 2005;214:198-209.
14. Abedi AR, Koohestani HR, Roosta Z. The short-term effect of chest physiotherapy on spirometric indices in chemical warfare victims exposed to mustard gas. Armaghane-danesh 2009;3-4:81-91.
15. Motimer KJ, Harrison TW, Tattersfield AE. Effects of inhaled corticosteroids on bone. Ann Allergy Asthma Immunol 2005;94:15-21.
16. Freitag L, Firusian N, Stamatis G, Greschuchna D. The role of bronchoscopy in pulmonary complications due to mustard gas inhalation. Chest 1991;100:1436-41.
17. Van Helden HP, Kuijpers WC, Diemel RV. Asthma like symptoms following intra tracheal exposure of Guinea pigs to sulfur mustard aerosol: Therapeutic efficacy of exogenous lung surfactant curosurf and salbutamol. Inhal Toxicol 2004;16:537-48.
18. Ando M, Mori A, Esaki H, Shiraki T, Uemura H, Okazawa M, et al. The effects of pulmonary rehabilitation in elderly patients. Nihon Kokyuki Gakkai Zasshi 2003;41:81-8.
19. Shohrati M, Aslani J, Eshragh M, Alaedini F, Ghanei M. Therapeutics effect of N-acetyl cysteine on mustard gas exposed patients: Evaluating clinical aspect in patients with impaired pulmonary function test. Respir Med 2008;102;443-8.
20. Riise GC, Larson S, Larson P, Jeansson S, Andersson BA. The intrabronchial microbial flora in chronic bronchitis patients: A target for N-acetyl cysteine therapy? Eur Respir J 1994;7:94-101.
21. Pela R, Calcagni AM, Subiaco S, Isidori P, Tubaldi A, Sanguinetti CM. N-Acetyl Cysteine reduces the exacerbation rate in patients with moderate to sever COPD. Respiration 1999;66:495-500.
22. Kasielski M, Nowak D. Long term administration of N-acetyl-cysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Respir Med 2001;95:448-56.
23. Hosseini K, Alavi S, Abedi AR. Reversibility of airflow obstructive pulmonary disease secondary to sulfur mustard gas injury. Arch Iran Med 1999;2:178-80.
24. Sohrabpour H, Roshan Zamir F, Aminorroaya AP. Comparison of acute bronchodilatory effects of inhaled salbotamol and combivent in mustard gas victims. Iran J Med Sci 1996;21:29-34.
25. Balali M, Navaian A. Clinical and para clinical findings in 233 patients with sulfur mustard poisoning. Proceeding of the second world congress chemical and biological warfare. Ghent, Belgium International Association of Forensic Toxicologists: 1986. p. 473-84.
26. Mehrtash B. Comparison of salbutamol and its combination with ipratropium bromide in chemically injured patients. J Qazvin Univ Med Sci 2002;21:23-7.
27. Boskabady MH, Farhadi J. The possible prophylactic effect of Nigella sativa seed aqueous extract on respiratory symptoms and pulmonary function tests on chemical war victims: A randomized, double-blind, placebo-controlled trial. J Altern Complement Med 2008;14:1137-44.
28. Ghanei M, Amini Harandi A. Long term consequences from exposure to sulfur mustard. Inhal Toxicol 2007;19:451-6.
29. Ognjen V. Anti-inflamatory effects of macrolide antibiotics. Eur J Pharmacol 2001;429:209-29.
30. Ghanei M, Hosseini Khalili A, Arab MJ, Mojtahedzadeh M, Aslani J, Lessan pezeshki M, et al. Diagnostic and therapeutic value of short-term corticosteroid therapy in exacerbation of mustard gas-induced chronic bronchitis. Basic Clin Pharmacol Toxicol 2005;97:302-5.
31. Attaran D, Mirsadraee M, Rajabian R, Saghafi M, Khajedalouee M, Towhidi M. Inhaled corticosteroids and bone density in chemical warfare patients with Pulmonary complication. Tanaffos Respir 2007;6:25-30.
32. Singh RF, Tattersfield A. Inhaled corticosteroid-induced bone loss and preventive strategies. J Am Osteopath Assoc 2000;100:S14-7.
33. Hubbard R, Tattersfield A. Inhaled corticosteroids, bone mineral density and fracture in older people. Drug Aging 2004;21:631-8.
34. Ghanei M, Panahi Y, Aslani J, Mojtahedzadeh M. Successful treatment of pulmonary obstructive lesion in chemical warfare casulties with Gamma-interferon. Kowsar Med J 2003;2:151-7.
35. Ghanei M, Aslani J, Panahi Y, Aghaei Meybodi SM, Hosseini SM. Evaluation of efficacy and effectiveness azithromycin and prednisolone in treatment of chronic pulmonary complication due to mustard gas. J Mil Med 2008;2:81-8.
36. Fleming T. PDR for herbal medicine. 2nd ed. Montvale, NJ: Medical Economic Co; 2008. p. 283.
37. Bayat M, Shahsavari S. Evaluation of effectiveness of thyme c.w (oral drop) on the improvement of respiratory function of patients with chemical bronchitis in kurdistan. J Mil Med 2005;4:293-7.
38. Boskabady MH, Attaran D, Shaffei MN. Airway responses to salbutamol after exposure to chemical warfare. Respirology 2008;13:288-293.
39. Michael J, Dacey MJ. Hypomagnesemic disorders. Crit Care Clin 2001;17:155-73.
40. Gourgoulianis Kl, Chtziparasidis G, Chatziefthimiou A, Molyvdas PA. Magnesium as a relaxing factor of airway smooth muscles. J Aerosol Med 2001;14:301-7.
41. Alamoudi OS. Hypo magneseamia in chronic, stable asthmatics. Prevalence, correlation with severity and hospitalization. Eur Respir J 2000;16:427-31.
42. Schenk P, Vonbank K, Schnack B, Haber P, Lehr S, Smertana R. Intravenous magnesium sulfate for bronchial hyperreactivity: A randomized, controlled, double-blind study. Clin Pharmacol Ther 2001;69:365-71.
43. Alamoudi OS. Electrolyte disturbances in patients with chronic, stable asthma: Effect of therapy. Chest. 2001;120:431-6.
44. Agin KH. Comparison of serum Magnesium values among sulfur mustard induced asthma with non-chemical asthmatic in iranian war victims. J Army Univ Med Sci I.R. Iran 2005;3:499-5.
45. Tavakolipour P, Sadeghi M, Heidari R, Vosough AA, Rabiei K. The effect of Sildenafil on the pulmonary artery hypertension caused by mustard gas. J Isfahan Med Sch 2008;26:279-85.
46. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, et al. Clinical classification of pulmonary hypertension. J Am Cll Cardiol 2004;43:S5-12.
47. Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1997;336:111-7.
48. Oudiz RJ, Roveran G, Hansen JE, Sun XJ, Wasserman K. Effect of sildenafil on ventilator efficiency and exercise tolerance in pulmonary hypertension. Eur J Heart Fail 2007;9:917-21.
49. Culpitt SV, Maziak W, Loukidis S, Nightingale JA, Matthews JL, Barnes PJ. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:1635-9.